Acrivon Therapeutics, Inc. · NASDAQ:ACRV

Miller Mary sold 513 Acrivon Therapeutics, Inc. shares (Form 4)

Traded Oct 22, 2026 · Filed Oct 26, 2026

On Oct 22, 2026, Miller Mary (Chief Legal Officer) sold 513 Acrivon Therapeutics, Inc. shares at US$1.84 for US$944, leaving 81,202 shares. Filed Oct 26, 2026 (Form 4).

Sold
513 shares
Price
US$1.84
Value
US$944
Holding after
81,202 shares
Trading plan
No
Role
Chief Legal Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 22, 2026Common StockSale513US$1.8481,202Direct

Source

Download original · View original at SEC

Related